{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:32:00Z","timestamp":1786480320368,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Hypertension is one of the leading causes of mortality related to cardiovascular disease. Since the advent of modern medicine, a multitude of efforts have been made to achieve better BP control. However, despite a wide range of monitoring protocols and medication therapies, only 23% of patients with hypertension achieve BP control. Renal denervation (RDN) has emerged as an adjunctive therapy to medications and lifestyle modification for BP control. Two methods of RDN were approved by the US Department of Food and Drug Administration in 2023: Radiofrequency ablation and an ultrasound-based method. Radiofrequency ablation uses heat-generating electrodes placed on the renal artery using a catheter and delivers heat through alternating current. Ultrasound-based technique uses ultrasonic heating to create a ring of ablative energy that interrupts renal nerve signaling. Over the past two decades, well-conducted randomized sham control trials and registry analysis have proven RDN to be an effective and safe treatment option for resistant hypertension with promising results. RDN also becomes appealing in patients with CKD who have an underlying sympathetic overactivity. This article aims to provide a comprehensive review of RDN, including current evidence and its implications in routine clinician practice.<\/jats:p>","DOI":"10.34067\/kid.0000000961","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:00:07Z","timestamp":1755108007000},"page":"2010-2016","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Renal Denervation"],"prefix":"10.34067","volume":"6","author":[{"given":"Sidrah","family":"Abid","sequence":"first","affiliation":[{"name":"Department of Nephrology, Albany Medical Center, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4687-9368","authenticated-orcid":false,"given":"Swati","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Albany Medical Center, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu","family":"Munazzah","sequence":"additional","affiliation":[{"name":"Fatima Jinnah Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3123-9431","authenticated-orcid":false,"given":"Neil","family":"Yager","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Albany Medical Center, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Baloch","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wyckoff Heights Medical Center, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-6196","authenticated-orcid":false,"given":"Krishnakumar","family":"Hongalgi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Albany Medical Center, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"10","key":"B1-20251120","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1161\/HYP.0000000000000240","article-title":"Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association","volume":"81","author":"Cluett","year":"2024","journal-title":"Hypertension."},{"issue":"4","key":"B2-20251120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.ajkd.2022.03.015","article-title":"Renal denervation: a review","volume":"80","author":"Rey-Garc\u00eda","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B3-20251120","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/ndt\/gfac189","article-title":"Renal denervation in patients with chronic kidney disease: current evidence and future perspectives","volume":"38","author":"Schmieder","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"B4-20251120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jch.12308","article-title":"Recently Published hypertension guidelines of the JNC 8 panelists, the American Society of Hypertension\/International Society of Hypertension and other major organizations: introduction to a focus issue of the journal of clinical Hypertension","volume":"16","author":"Weber","year":"2014","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"4","key":"B5-20251120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"2","key":"B6-20251120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.HYP.0000173433.67426.9b","article-title":"Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis","volume":"46","author":"Franco","year":"2005","journal-title":"Hypertension."},{"issue":"1","key":"B7-20251120","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1038\/s41598-018-27377-2","article-title":"Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III linked mortality study","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci Rep."},{"issue":"2","key":"B8-20251120","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.cpcardiol.2023.102196","article-title":"The role of renal denervation in cardiology and beyond: an updated comprehensive review and future directives","volume":"49","author":"Goyal","year":"2024","journal-title":"Curr Probl Cardiol."},{"issue":"2","key":"B9-20251120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tcm.2024.08.005","article-title":"The current state and future of renal denervation: a review","volume":"35","author":"Maini","year":"2025","journal-title":"Trends Cardiovasc Med."},{"issue":"10","key":"B10-20251120","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1097\/HJH.0000000000003236","article-title":"Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model","volume":"40","author":"Sharp","year":"2022","journal-title":"J Hypertens."},{"issue":"4","key":"B11-20251120","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/HYPERTENSIONAHA.114.05010","article-title":"First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension","volume":"65","author":"B\u00f6hm","year":"2015","journal-title":"Hypertension."},{"issue":"5","key":"B12-20251120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCULATIONAHA.118.037654","article-title":"A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN)","volume":"139","author":"Fengler","year":"2019","journal-title":"Circulation."},{"issue":"7","key":"B13-20251120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","article-title":"Anatomic assessment of sympathetic peri-arterial renal nerves in man","volume":"64","author":"Sakakura","year":"2014","journal-title":"J Am Coll Cardiol."},{"issue":"19","key":"B14-20251120","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","article-title":"Safety and efficacy of renal denervation in patients taking antihypertensive medications","volume":"82","author":"Kandzari","year":"2023","journal-title":"J Am Coll Cardiol."},{"issue":"8","key":"B15-20251120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA."},{"issue":"22","key":"B16-20251120","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/CIRCULATIONAHA.119.040451","article-title":"Six-month results of treatment-blinded medication titration for hypertension control after randomization to endovascular ultrasound renal denervation or a sham procedure in the RADIANCE-HTN SOLO trial","volume":"139","author":"Azizi","year":"2019","journal-title":"Circulation."},{"issue":"10293","key":"B17-20251120","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet."},{"issue":"11","key":"B18-20251120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2014.05.012","article-title":"Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3","volume":"64","author":"Bakris","year":"2014","journal-title":"J Am Coll Cardiol."},{"issue":"6","key":"B19-20251120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/HYPERTENSIONAHA.115.05283","article-title":"Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension","volume":"65","author":"Desch","year":"2015","journal-title":"Hypertension."},{"issue":"8","key":"B20-20251120","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/HJH.0000000000000977","article-title":"Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial","volume":"34","author":"Mathiassen","year":"2016","journal-title":"J Hypertens."},{"issue":"10333","key":"B21-20251120","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet."},{"key":"B22-20251120","doi-asserted-by":"crossref","first-page":"e06","DOI":"10.15420\/icr.2022.38","article-title":"Renal denervation: a practical guide for health professionals managing hypertension","volume":"18","author":"Schmieder","year":"2023","journal-title":"Interv Cardiol."},{"issue":"13","key":"B23-20251120","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2018.12.082","article-title":"Sham-controlled randomized trials of catheter-based renal denervation in patients with hypertension","volume":"73","author":"Sardar","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"26","key":"B24-20251120","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehu209","article-title":"Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial","volume":"35","author":"Esler","year":"2014","journal-title":"Eur Heart J."},{"issue":"15","key":"B25-20251120","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med."},{"issue":"6Part A","key":"B26-20251120","first-page":"101121","article-title":"SCAI position statement on renal denervation for hypertension: patient selection, operator competence, training and techniques, and organizational recommendations","volume":"2","author":"Swaminathan","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv."},{"issue":"15","key":"B27-20251120","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehad054","article-title":"Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC council on hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"44","author":"Barbato","year":"2023","journal-title":"Eur Heart J."},{"issue":"23","key":"B28-20251120","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.jacc.2020.04.036","article-title":"Renal denervation in high-risk patients with hypertension","volume":"75","author":"Mahfoud","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B29-20251120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2017.01.047","article-title":"Effect of renal denervation on kidney function in patients with chronic kidney disease","volume":"232","author":"Hering","year":"2017","journal-title":"Int J Cardiol."},{"issue":"1","key":"B30-20251120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41371-023-00857-3","article-title":"Effects of renal denervation on kidney function in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"38","author":"Mohammad","year":"2024","journal-title":"J Hum Hypertens."},{"issue":"6","key":"B31-20251120","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","article-title":"Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension","volume":"33","author":"Ott","year":"2015","journal-title":"J Hypertens."},{"issue":"2","key":"B32-20251120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension","volume":"60","author":"Mahfoud","year":"2012","journal-title":"Hypertension."},{"issue":"42","key":"B33-20251120","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the global SYMPLICITY registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur Heart J."},{"issue":"1","key":"B34-20251120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jch.14605","article-title":"Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension","volume":"25","author":"Liu","year":"2023","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"1","key":"B35-20251120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4244\/EIJ-D-19-00902","article-title":"Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation","volume":"16","author":"Townsend","year":"2020","journal-title":"EuroIntervention."},{"issue":"9","key":"B36-20251120","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/ndt\/gfx088","article-title":"Renal safety of catheter-based renal denervation: systematic review and meta-analysis","volume":"32","author":"Sanders","year":"2017","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"B38-20251120","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3390\/jcm14103554","article-title":"Renal denervation after USA FDA approval: an update from an interventional cardiologist's perspective","volume":"14","author":"Zhang","year":"2025","journal-title":"J Clin Med."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:37Z","timestamp":1786478617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000961"}},"subtitle":["A New Era in the Management of Resistant Hypertension"],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000961","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}